Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 154

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1A
Chunk 154
---
We operate in a rapidly changing environment that involves numerous uncertainties and risks. In addition to the other information included in this Annual Report on Form 10-K, the following risks and uncertainties may have a material and adverse effect on our business, financial condition, results of operations, or stock price. You should consider these risks and uncertainties carefully, together with all of the other information included or incorporated by reference in this Annual Report on Form 10-K. The risks and uncertainties described below may not be the only ones we face. If any of the risks or uncertainties we face were to occur, the trading price of our securities could decline, and you may lose all or part of your investment. This Annual Report on Form 10-K also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of factors that are described below and elsewhere in this report. 

Risk factors include, but are not limited to, statements concerning the following:

Risks related to our business and strategy:

•the intense international, national, regional and local competition we face in our industry;

•our dependence on a limited number of customers for a significant portion of our sales revenue;

•our reliance on a single source or a limited group of manufacturers or suppliers;

•the lack of long-term supply contracts with many of our third-party suppliers;

•the need to continue to enhance our existing products and develop and market new products;

•potential acquisitions of, or investments in, other companies;

•the complex and lengthy reimbursement process we depend upon for a significant portion of our revenue;

•increases in our operating costs;

•economic impacts that affect customer and consumer spending as well as demand for our products;

•public health threats and epidemics;

•the competitive bidding process or other reimbursement policy changes under Medicare or other third-party payors, including recently enacted and potential future changes in the reimbursement rates or payment methodologies under Medicare, Medicaid and other government programs;

•consolidation in the healthcare industry;

•healthcare reform measures;

•the possibility our manufacturing facilities could become unavailable or inoperable and other potential manufacturing problems or delays;

•our reliance upon a third-party contract manufacturer for certain manufacturing and repair operations;

•potential failure to maintain or obtain new private payor contracts and future reductions in reimbursement rates from private payors;

•the possibility of non-payment of our HME providers, distributors, private label partners and resellers;

•our international sales and manufacturing activities;

•warranty or product liability claims or other